Cargando…
Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques
BACKGROUND: Emergence of drug-resistant strains of human immunodeficiency virus type 1 (HIV-1) is a major obstacle to successful antiretroviral therapy (ART) in HIV-infected patients. Whether antiviral immunity can augment ART by suppressing replication of drug-resistant HIV-1 in humans is not well...
Autores principales: | Metzner, Karin J, Binley, James M, Gettie, Agegnehu, Marx, Preston, Nixon, Douglas F, Connor, Ruth I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769512/ https://www.ncbi.nlm.nih.gov/pubmed/17184540 http://dx.doi.org/10.1186/1742-4690-3-97 |
Ejemplares similares
-
Effects of in Vivo Cd8(+) T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine
por: Metzner, Karin J., et al.
Publicado: (2000) -
Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques
por: Amedee, Angela M, et al.
Publicado: (2004) -
Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques
por: Aravantinou, Meropi, et al.
Publicado: (2017) -
MHC and KIR Polymorphisms in Rhesus Macaque SIV Infection
por: Walter, Lutz, et al.
Publicado: (2015) -
Increased cellular immune responses and CD4+ T-cell proliferation correlate with reduced plasma viral load in SIV challenged recombinant simian varicella virus - simian immunodeficiency virus (rSVV-SIV) vaccinated rhesus macaques
por: Pahar, Bapi, et al.
Publicado: (2012)